News

Inotiv Celebrates Growth as a Top Technology Innovator

Inotiv Celebrates Growth as a Top Technology Innovator

Inotiv Recognized Among Fastest-Growing North American Companies

Inotiv has made significant strides, being recognized as the 182nd fastest-growing company on the Deloitte Technology Fast 500™ list. This prestigious ranking highlights the top technology companies across various sectors in North America. The honor showcases Inotiv’s incredible revenue growth of 448% from fiscal year 2021 to 2024, marking a notable period of expansion and success for the organization.

A Commitment to Client Care and Strategic Growth

Robert Leasure, Jr., who serves as the President and CEO of Inotiv, attributes this remarkable achievement to the dedication that the company has shown to its clients, and the strategic initiatives that have been put in place. Leasure highlights the importance of collaborative partnerships and innovative solutions in contributing to Inotiv's consistent growth. "It is with great honor that we receive the Deloitte Technology Fast 500™ recognition for the third year in a row. This reflects the trust and partnership that our clients have with us," he stated. He further emphasized that the company is focused on enhancing its capabilities through strategic acquisitions and developing services that meet clients’ evolving needs.

Understanding the Deloitte Technology Fast 500

The Deloitte Technology Fast 500™ acknowledges the fastest-growing companies based on their revenue growth over a substantial fiscal period. This year’s list features a blend of established and emerging innovators, demonstrating the dynamic nature of the market. Wolfe Tone from Deloitte expressed that this year’s ranking reflects both enduring stronghold leaders and exciting newcomers. The success of private companies, like Inotiv, highlights the agility and rapid growth potential that smaller firms can achieve in competitive sectors.

Inotiv's Continued Growth and Recognition

This is not the first time Inotiv has gained recognition as part of the Technology Fast 500. The company previously ranked 138th in 2024 and 127th in 2023. As Inotiv continues to innovate and expand, it is establishing itself as a prominent name in the life sciences sector.

Key Achievements and Services of Inotiv

Inotiv, Inc. specializes in providing nonclinical and analytical drug discovery and development services essential to the pharmaceutical sector. The company’s offerings include research models and complementary services that ensure efficient pathways for bringing new drugs and medical devices to market. Their commitment to enhancing research objectives and supporting development phases is pivotal in aiding researchers in their critical projects.

Company Eligibility and Growth Requirements

To be honored in the Deloitte Technology Fast 500, companies must meet specific criteria. They need to possess proprietary technology that contributes significantly to revenue, must have a solid revenue base starting at US$50,000, and show current revenues of at least US$5 million with a growth rate of 50% or more. Additionally, companies must have been in operation for a minimum of four years and have their headquarters located within North America.

Frequently Asked Questions

What is the Deloitte Technology Fast 500™?

The Deloitte Technology Fast 500™ is an annual ranking that highlights the fastest-growing technology, media, and telecommunications companies in North America.

How did Inotiv achieve its ranking?

Inotiv’s ranking was achieved through substantial revenue growth of 448% from fiscal year 2021 to 2024, showcasing their success and strategic advancements in the industry.

Who is Inotiv?

Inotiv, Inc. is a contract research organization that focuses on providing services related to drug discovery and development, including nonclinical research and development models.

What does this ranking mean for Inotiv's future?

This recognition positions Inotiv as a key player in the life sciences sector, likely paving the way for even greater opportunities in partnerships and market presence.

How can I contact Inotiv for more information?

You can reach out to Inotiv's Financial Officer, Beth A. Taylor, at (765) 497-8381 or via email at beth.taylor@inotiv.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Biogen's Stock Hits Yearly Low: Market Trends and Analyst Insights

Updated Category News Views 321

Biogen's Current Stock Performance Biogen Idec Inc (NASDAQ: BIIB) is experiencing a significant downturn, recently reaching a 52-week low of $144.96. This predicament is attributed to various market pressures and internal challenges affecting the biotechnology sector. With a current market capitalization of approximately $21.2 billion, the company has faced mounting...

Continue Reading
Dana Incorporated Welcomes Nora LaFreniere to Board of Directors

Updated Category News Views 198

Dana Incorporated Appoints Nora LaFreniere to the Board Dana Incorporated (NYSE: DAN) recently announced the addition of Nora LaFreniere to its board of directors, effective immediately. This decision marks an important step for Dana as it continues to focus on strategic growth and innovation in the mobility solutions sector. Professional Background of Nora LaFreniere...

Continue Reading
On Holding AG: Riding the Wave of Growth and Innovation

Updated Category News Views 266

On Holding AG Thrives with Strategic Growth Initiatives On Holding AG (NYSE: ONON) has witnessed an impressive surge of nearly 20% recently, showcasing its astonishing performance in the sneaker market. The latest earnings report reveals that the Swiss sneaker manufacturer is not just maintaining its position but is actively exceeding the competition from major players...

Continue Reading
Citizens Bank to Redeem Senior Notes, Enhancing Financial Strategy

Updated Category News Views 34

Citizens Bank Announces Redemption of Senior Notes Citizens Bank, N.A. has made an important announcement regarding the redemption of its Senior Notes. This strategic move involves all of the bank's outstanding 6.064% Fixed/Floating Rate Senior Notes, amounting to a significant total of $600,000,000. The redemption price will correspond to 100% of the principal amount of...

Continue Reading
Impressive Financial Growth in VitalHub's Q3 Report

Updated Category News Views 136

Overview of VitalHub's Q3 Performance VitalHub Corp. reported significant financial achievements for the third quarter of 2025. The company's Annual Recurring Revenue (ARR) saw a remarkable growth of 75% from the previous year, reaching $93.7 million. Alongside this, total revenue surged by 94% year-over-year, amounting to an impressive $32.0 million. Adjusted Earnings...

Continue Reading